Compare American Airlines Group Inc (AAL) vs Alnylam Pharmaceuticals, Inc. (ALNY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Airlines Group Inc vs Alnylam Pharmaceuticals, Inc. — how do they compare? American Airlines Group Inc trades at $16.43 (market cap $11.38B), while Alnylam Pharmaceuticals, Inc. trades at $322 (market cap $42.94B). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 3.8× American Airlines Group Inc's market cap, and American Airlines Group Inc is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| AAL | ALNY | |
|---|---|---|
Market Cap | $11.38B | $42.94B |
Sector | Industrials | Health |
52-Week High | $18.15 | $491.22 |
52-Week Low | $10.18 | $278.09 |
Enterprise Value | $38.97B | $41.20B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Airlines Group Inc
American Airlines is the world's largest airline by scheduled revenue passenger miles. The firm's major hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. After completing a major fleet renewal, the company has the youngest fleet of U.S. legacy carriers.
Read more on AAL →About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →
